Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Kazakhstan to Launch Production of Russian Vaccine

Moskva News Agency

Ex-Soviet Kazakhstan said Friday it will begin producing Russia's coronavirus vaccine later this month, becoming the latest country to do so as a global inoculation race heats up.

Russia last month said its Sputnik V drug was 95% effective and would be cheaper and easier to store than some alternatives. 

President Vladimir Putin has called on Moscow's allies to mass produce the country's vaccines. 

In a statement on Friday, Kazakhstan's presidency said the country would begin producing Sputnik V from Dec. 22, with plans to begin inoculating vulnerable groups in early 2021.

The developers of Sputnik V — named after the Soviet-era satellite — have said the jab will be available on international markets for less than $10 (8.40 euros) per dose. 

They have also said it can be stored at between two and eight degrees Celsius (between 35.6 and 46.4 degrees Fahrenheit) instead of the temperatures far below freezing required for some other vaccines.

Russia was one of the first to announce the development of a vaccine in August but before beginning final clinical trials.

The jab is currently in its third and final stage of clinical trials slated to involve some 40,000 volunteers.

Western experts have in the past expressed concern over Sputnik V, fearing that its development could be rushed.

Several welcomed the most recent efficacy figures, though they said more data was needed.

Russia's trade and industry ministry on Thursday said it had delivered samples of the vaccine to Uzbekistan.

The ministry added that the country has agreed to production deals with countries including India, Brazil, China and South Korea.

On Friday Serbia announced it had received a 20-dose trial batch of Sputnik V.

Last month Russia sent samples of the vaccine to EU member Hungary, in the face of concerns from Brussels. 

… we have a small favor to ask. As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

paiment methods
Not ready to support today?
Remind me later.

Read more